Production Snag Forces Worldwide Hold On GlaxoSmithKline Chickenpox Vaccines

Published: Jan 28, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GlaxoSmithKline has stopped worldwide deliveries of two chickenpox vaccines for children after discovering that some batches produced at its factory in Wavre, Belgium, were not up to standard. Britain's biggest drugmaker, which is also one of the world's leading vaccine manufacturers, said on Tuesday it expected shipments to begin again at the end of the first quarter. The quality issue affects two vaccines containing a varicella (chickenpox) component - Priorix-Tetra, a combined vaccine for measles, mumps, rubella and varicella, known as MMRV, and Varilrix, a single chickenpox shot.

Help employers find you! Check out all the jobs and post your resume.

Back to news